Teva Completes Enrollment in Laquinimod Phase III Clinical Trial

November 18, 2008 08:00 (CET)
Contact:                
Elana Holzman, Teva Pharmaceutical Industries Ltd.,  +972 3 926-7554
Kevin Mannix,  Teva North America, +1 215 591-8912
Tomas Leanderson, Active Biotech AB, +46 46 19 20 95
Göran Forsberg, Active Biotech AB, +46 46 19 11 54
 
Teva Completes Enrollment in Laquinimod Phase III Clinical Trial